Filing Details
- Accession Number:
- 0000880771-16-000190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-30 16:41:18
- Reporting Period:
- 2016-08-26
- Filing Date:
- 2016-08-30
- Accepted Time:
- 2016-08-30 16:41:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
880771 | Sciclone Pharmaceuticals Inc | SCLN | Pharmaceutical Preparations (2834) | 943116852 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1135041 | T Nancy Chang | 950 Tower Lane, Suite 900 Foster City CA 94404-2125 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-08-26 | 7,500 | $10.25 | 17,540 | No | 4 | S | Indirect | by Partnership |
Common Stock | Disposition | 2016-08-29 | 10,000 | $10.31 | 7,540 | No | 4 | S | Indirect | by Partnership |
Common Stock | Disposition | 2016-08-30 | 7,540 | $10.33 | 0 | No | 4 | S | Indirect | by Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by Partnership |
No | 4 | S | Indirect | by Partnership |
No | 4 | S | Indirect | by Partnership |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 29,019 | Direct |